Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ADCYAP1	PACAP	ENSG00000141433	"Adenylate cyclase activating polypeptide 1"	P18509	18	904943-912172	"Predicted secreted proteins"	Neurogenesis	Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;lymphoid tissue: 16.5"	"Cell type enriched"	"Detected in some"	12	"granulocytes: 42.7"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"SCLC-21H: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065887	Supported	Supported			"Secreted in other tissues"	NA	NA					"HPA065887: "	"unprognostic (2.68e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.87e-4)"	"unprognostic (9.58e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.86e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (2.91e-6)"	"unprognostic (2.24e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.74e-4)"	2.1	0.5	2.5	16.5	7.7	0.1	1.6	2.1	12.5	3.4	2.6	0.8	0.0	0.1	4.0	0.1	2.2	0.5	12.3	1.0	1.2	18.4	0.6	0.3	1.7	1.6	2.8	6.2	0.2	7.7	0.1	4.5	0.3	33.8	1.4	1.4	2.5	2.2	1.0	0.3	0.9	1.3	1.5	5.9	0.2	1.8	3.6	0.2	0.1	0.3	0.0	1.4	3.1	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.7	2.1	12.1	1.2	18.4	2.8	6.2	33.8	0.2	3.0	1.1	0.0	0.0	0.6	0.1	0.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	42.7	0.0	0.1	0.0	0.0	0.6	0.0	1.0	0.3	0.3	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.0	0.0	0.0	0.1
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058242-131089883	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Region enriched"	"Detected in many"	5	"hypothalamus: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	164	"SH-SY5Y: 64.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 104.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1"	"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		Yes	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		6.9	58.4	1.4	0.2	3.6	0.1	1.0	0.0	2.7	0.5	0.2	0.0	0.0	0.1	0.1	2.0	0.3	0.2	0.2	0.1	1.0	25.5	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	50.3	0.3	5.4	0.3	0.2	0.6	0.2	0.2	13.7	0.1	0.1	0.1	0.8	0.1	0.2	0.6	0.0	0.5	0.5	4.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	64.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.6	0.0	0.4	1.0	25.5	0.5	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0
AVPR1B	AVPR3	ENSG00000198049	"Arginine vasopressin receptor 1B"	P47901	1	206109692-206117699	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"pituitary gland: 52.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"renal cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;NTERA-2: 1.0;PC-3: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075404	Enhanced					NA	NA					"HPA075404: AB_2732291"		"unprognostic (4.87e-2)"		"unprognostic (1.44e-1)"	"unprognostic (4.82e-1)"			"unprognostic (2.82e-1)"		"unprognostic (2.87e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.66e-3)"	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.5	0.1	1.3	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	52.8	0.1	0.1	0.2	0.8	0.0	0.0	0.4	0.0	0.0	1.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	1.0	0.0	3.6	0.0	0.0	0.2	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621818	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"		Yes	No			"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	8.4	7.5	9.3	7.6	11.7	6.5	12.0	31.0	15.1	11.7	11.0	9.6	7.6	5.9	12.7	12.7	6.7	12.9	7.6	8.4	9.8	6.4	9.2	4.6	7.7	10.1	10.8	10.6	14.7	7.1	10.1	32.9	7.6	11.0	9.7	9.4	7.8	9.1	10.9	11.9	5.7	7.7	11.1	11.2	8.7	8.0	8.6	12.9	11.9	12.1	5.7	10.2	11.0	9.7	2.6	1.1	7.0	2.2	5.0	14.1	2.7	5.5	1.9	6.2	3.7	9.3	5.6	4.9	7.1	6.5	9.4	8.3	4.3	4.4	15.5	1.6	3.8	6.1	3.1	3.4	6.5	10.5	5.5	4.2	9.7	8.6	4.9	6.6	12.4	3.6	5.4	9.4	7.8	5.5	8.3	5.9	7.9	9.0	2.4	7.2	4.5	9.9	7.9	10.1	4.7	7.7	3.3	5.3	8.3	5.6	1.9	2.3	4.3	8.6	5.5	5.3	5.5	1.9	5.4	3.2	7.0	5.5	6.5	9.6	5.0	5.3	8.3	5.2	14.2	5.5	7.0	1.5	3.3	4.3	1.9	5.6	2.6	7.4	5.3	1.1	1.7	8.6	6.2	0.3	5.0	2.2	1.0	14.1	2.7	9.3	11.7	31.0	15.1	9.8	6.4	10.8	10.6	11.0	12.9	20.8	19.9	24.5	21.3	25.0	66.8	26.9	25.5	57.6	35.2	21.0	102.1	17.7	24.9	17.3	158.6	28.7	8.0	23.3	9.1	11.3	30.0	13.3	33.5	7.5	16.2	49.3	20.2	27.0	26.2	74.4	50.0	20.8	25.3	43.3	9.4	34.0	13.6	10.2	44.9	16.5	99.9	32.3	30.2	49.7	45.4	25.7	13.7	47.3	13.6	9.5
CGA	"FSHA, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095406	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"pituitary gland: 398.8;placenta: 489.3"	"Cell type enriched"	"Detected in some"	30	"Syncytiotrophoblasts: 71349.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 13.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"BEWO: 73.5;SuSa: 141.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hypothalamus: 69.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"	NA	NA					"CAB023350: AB_617281, HPA029698: AB_2673153"	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	398.8	489.3	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.6	0.0	0.1	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.2	1.9	3.5	1.5	1.1	2.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	73.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	141.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.3	1.1	1.0	1.7	0.5	0.7	1.3	0.8	1.4	0.6	2.2	1.2	2.1	3.5	1.1	1.5	1.9	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	0.0	1223.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2346.5	0.1	1.5	0.0	0.0	567.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	71349.9	0.0	0.0	0.3
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911430-5925361	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 424.9;pituitary gland: 177.5"	"Cell type enriched"	"Detected in many"	11	"Intestinal endocrine cells: 997.5"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.6;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Group enriched"	"Detected in some"	23	"SCLC-21H: 66.7;SH-SY5Y: 102.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		24000000	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	3.4	424.9	8.2	1.4	10.2	0.8	1.0	82.5	16.4	0.8	3.0	2.1	1.2	7.7	0.9	1.3	0.8	2.5	0.8	7.6	20.7	15.4	1.7	0.7	1.0	1.1	7.2	9.1	3.0	17.0	0.8	177.5	0.8	51.8	5.6	2.5	0.7	0.9	1.2	2.1	0.9	4.4	0.9	2.3	0.8	19.7	2.4	0.8	0.0	1.9	0.4	0.9	0.8	0.1	0.0	0.6	0.0	0.0	0.0	2.6	0.2	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.7	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	66.7	102.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.2	8.2	10.2	82.5	16.4	20.7	15.4	7.2	9.1	51.8	0.8	3.0	3.7	0.0	8.2	3.8	86.9	51.2	0.0	8.1	1.2	66.3	19.6	0.0	1.7	0.4	6.1	3.4	1.7	0.0	0.3	0.0	2.3	2.3	0.0	0.0	0.1	71.5	997.5	0.0	0.3	6.0	0.9	1.5	6.8	1.8	2.8	9.3	37.4	5.8	0.4	0.1	49.6	12.9	1.4	50.2	27.7	3.1	0.2	0.0	1.4	3.0
CHST14	"D4ST-1, D4ST1, HD4ST"	ENSG00000169105	"Carbohydrate sulfotransferase 14"	Q8NCH0	15	40470998-40474571	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 39.3;Extravillous trophoblasts: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057697, HPA071601"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA057697: AB_2683505, HPA071601: AB_2686425"	"unprognostic (5.46e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.01e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.25e-2)"	10.3	7.9	7.1	7.5	6.9	2.3	22.7	6.5	7.4	14.9	7.9	6.0	13.8	3.6	17.5	11.1	6.5	12.3	14.1	12.6	5.5	2.9	8.1	9.6	15.9	20.9	8.1	4.5	18.8	11.6	10.2	11.4	22.4	7.1	10.7	3.8	9.8	12.7	17.2	5.5	6.8	7.1	13.3	5.9	10.5	7.3	9.2	6.3	7.5	12.4	8.3	6.1	12.1	18.2	2.1	3.4	8.0	1.9	5.5	4.0	1.1	10.6	7.0	11.3	30.4	17.7	13.7	17.6	10.5	20.0	18.6	17.7	8.5	5.4	1.7	16.1	17.8	33.0	18.3	10.0	5.9	8.8	12.7	5.8	5.4	7.5	8.1	9.6	2.3	14.2	16.7	4.9	6.5	5.0	20.6	16.3	6.3	5.3	6.4	13.8	8.0	3.8	12.2	7.2	3.2	8.2	10.7	14.3	3.0	12.4	5.5	8.2	12.5	9.2	10.4	3.4	14.4	15.1	9.8	13.3	31.6	11.7	9.9	10.4	12.9	8.9	4.9	14.2	8.0	22.7	8.0	1.9	3.6	4.0	1.9	1.1	0.5	2.0	3.4	3.4	2.1	1.8	1.4	0.3	5.5	0.9	1.2	1.3	1.1	7.1	6.9	6.5	7.4	5.5	2.9	8.1	4.5	7.1	6.3	11.9	1.4	2.4	4.3	3.1	0.4	2.5	7.6	4.0	5.7	3.5	0.0	39.3	0.0	6.5	1.4	6.3	0.1	0.0	4.3	26.3	14.6	2.6	4.6	2.6	7.9	1.6	2.4	15.4	5.1	0.9	16.4	4.3	5.0	2.8	1.7	9.3	4.6	0.0	11.0	1.0	0.6	6.5	5.6	8.0	1.6	2.3	11.3	5.4	1.5	1.0
CHST8	GALNAC-4-ST1	ENSG00000124302	"Carbohydrate sulfotransferase 8"	Q9H2A9	19	33621955-33773509	"Disease related genes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 27.1;pituitary gland: 36.7"	"Cell type enhanced"	"Detected in some"	26	"Early spermatids: 12.0;Late spermatids: 40.2;Smooth muscle cells: 7.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 18.8;SCLC-21H: 11.0;SH-SY5Y: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016004	Enhanced				"Intracellular and membrane"	NA	NA					"HPA016004: AB_1846731"	"unprognostic (1.00e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.98e-8)"	"unprognostic (9.37e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.87e-2)"	2.0	3.8	3.6	1.7	2.8	0.4	7.0	16.6	9.2	3.4	1.1	1.0	0.0	0.5	1.3	0.4	0.7	2.0	4.0	0.8	9.2	7.9	0.5	0.7	0.6	2.0	5.3	1.5	1.4	3.4	0.4	36.7	0.4	27.1	1.8	0.5	1.4	0.7	0.8	0.6	0.9	0.8	0.8	7.2	3.3	0.9	2.9	0.9	0.0	0.6	0.3	1.4	0.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	3.9	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.9	0.0	0.0	0.0	0.1	18.8	0.0	0.3	11.0	19.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.6	2.8	16.6	9.2	9.2	7.9	5.3	1.5	27.1	0.9	0.0	0.0	0.0	0.4	0.7	2.7	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.5	0.0	0.0	0.0	1.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	4.8	0.0	7.8	0.5	0.6	0.1	0.0	0.0	0.0	0.7
CNR1	"CANN6, CB-R, CB1, CB1A, CB1K5, CNR"	ENSG00000118432	"Cannabinoid receptor 1"	P21554	6	88139864-88166359	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5"	"Cell type enriched"	"Detected in some"	14	"Sertoli cells: 97.0"	"Cancer enriched"	"Detected in many"	13	"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.9"	"Group enriched"	"Detected in some"	7	"ASC diff: 40.3;HSkMC: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042256, HPA069945"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane"	"Actin filaments"	"HPA042256: AB_2677917, HPA069945: "	"unprognostic (1.28e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.00e-2)"	19.4	6.4	18.0	5.2	15.8	1.5	14.9	13.8	30.5	3.9	5.5	0.8	0.8	2.3	3.1	4.7	3.7	5.5	3.6	1.4	17.6	7.7	0.9	0.7	6.4	6.5	2.3	14.7	4.1	1.8	1.3	18.3	5.2	4.2	1.5	5.1	0.0	4.3	4.0	1.7	2.4	4.2	5.8	3.2	2.3	2.3	2.7	2.8	0.0	2.6	0.0	9.9	2.7	3.1	2.9	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	40.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.9	1.4	0.0	2.6	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	18.0	15.8	13.8	21.4	17.6	7.7	2.3	14.7	4.2	2.8	0.0	7.2	2.7	0.4	0.6	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	97.0	2.3	0.0	0.1	0.1	0.1	0.0	0.0	0.7
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914006	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 46.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 30.8;Late spermatids: 25.2;Muller glia cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.9;RT4: 10.2;SCLC-21H: 6.9;U-2 OS: 5.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	12.0	0.2	1.3	1.1	0.0	0.1	6.8	1.1	1.3	0.7	1.4	10.8	0.3	2.4	1.9	0.2	0.5	0.4	0.2	0.3	0.8	2.8	0.1	0.1	0.5	0.3	0.0	0.3	0.2	1.7	46.5	0.0	1.9	4.7	0.1	1.6	0.8	5.1	0.5	0.1	0.4	2.2	1.8	0.3	3.7	0.8	0.1	1.4	0.3	0.7	1.7	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	10.2	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.8	0.3	0.3	0.8	0.3	0.0	1.9	0.1	0.0	0.0	0.0	2.8	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	30.8	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	25.2	0.3	0.0	0.0	1.0	0.0	26.2	2.1	0.0	0.0	0.0	1.1	0.0	0.3	1.1	0.8	0.0	0.0	0.0	0.0	1.3
CRHR1	"CRF-R, CRF1, CRHR"	ENSG00000120088	"Corticotropin releasing hormone receptor 1"	P34998	17	45784280-45835828	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"brain: 23.2;pituitary gland: 16.5"	"Group enriched"	"Detected in some"	13	"Early spermatids: 37.9;Late spermatids: 37.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RT4: 8.1;SH-SY5Y: 5.0"									CAB025251	Enhanced				"Intracellular and membrane"	NA	NA					"CAB025251: "	"unprognostic (4.59e-2)"	"unprognostic (1.43e-2)"		"unprognostic (2.59e-7)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"		"unprognostic (3.94e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.55e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-4)"	"unprognostic (2.07e-5)"	"unprognostic (3.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	0.8	0.6	14.7	0.5	5.1	0.5	1.5	23.2	11.5	1.4	0.6	1.1	0.0	0.8	2.7	1.1	0.5	1.6	0.7	0.5	3.2	2.2	0.6	0.5	0.6	0.5	1.8	5.2	0.6	0.5	0.6	16.5	0.6	2.9	1.3	0.6	1.9	1.2	2.5	0.6	1.4	1.0	1.2	1.0	0.5	0.5	1.0	2.8	0.0	0.9	0.0	0.5	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.6	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	5.1	23.2	11.5	3.2	2.2	1.8	5.2	2.9	2.8	0.0	0.0	0.0	1.1	1.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.5	0.0	0.1	2.3	1.5	2.9	0.0	0.0	0.0	0.5
CSH1	"CSA, CSMT, FLJ75407, hCS-A, PL"	ENSG00000136488	"Chorionic somatomammotropin hormone 1"	P0DML2	17	63894909-63896661	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	29	"placenta: 450.4"	"Group enriched"	"Detected in some"	22	"Extravillous trophoblasts: 439.3;Syncytiotrophoblasts: 913.5"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 12.0;SuSa: 18.9"									"CAB026374, HPA043715"	Enhanced				"Secreted to blood"	NA	NA					"CAB026374: , HPA043715: AB_2678632"															"unprognostic (6.99e-2)"			2.6	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	15.7	450.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	1.9	0.1	1.0	0.9	0.8	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	439.3	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	913.5	0.0	0.0	0.0
CSH2	"CS-2, CSB, hCS-B"	ENSG00000213218	"Chorionic somatomammotropin hormone 2"	P0DML3	17	63872012-63873766	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	36	"placenta: 246.2"	"Cell type enriched"	"Detected in some"	25	"Syncytiotrophoblasts: 230.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"BEWO: 10.2;SuSa: 15.3"									HPA043715	Supported				"Secreted to blood"	NA	NA					"HPA043715: AB_2678632"		"unprognostic (1.68e-1)"								"unprognostic (1.85e-1)"					"unprognostic (1.86e-1)"			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.7	246.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.4	0.0	0.0	0.0
CSHL1	"CS-5, CSHP1, CSL, hCS-L, MGC149868"	ENSG00000204414	"Chorionic somatomammotropin hormone like 1"	Q14406	17	63909597-63918838	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	864	"pituitary gland: 334.1;placenta: 293.7"	"Cell type enriched"	"Detected in some"	16	"Syncytiotrophoblasts: 18.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.2;SCLC-21H: 1.3;SuSa: 1.7"									"CAB025646, HPA043715"	Enhanced				"Secreted to blood"	NA	NA					"CAB025646: , HPA043715: AB_2678632"																		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	334.1	293.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	18.1	0.0	0.0	0.0
CSRNP3	"FAM130A2, FLJ32093, PPP1R73, TAIP-2"	ENSG00000178662	"Cysteine and serine rich nuclear protein 3"	Q8WYN3	2	165469647-165689407	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.7;pituitary gland: 21.1"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 49.8;Cone photoreceptor cells: 66.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.9;PC-3: 3.1;SCLC-21H: 9.5;SH-SY5Y: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017905	Approved		Uncertain	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoli rim"	Nucleoplasm	"HPA017905: AB_1857757"	"unprognostic (2.85e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.08e-2)"	2.1	5.5	9.3	1.4	24.9	0.7	6.7	8.8	31.7	5.7	2.0	3.2	0.4	2.1	6.3	2.3	2.0	2.5	2.5	3.4	9.3	10.2	3.7	1.8	1.4	1.1	5.3	13.2	7.8	8.0	6.0	21.1	1.1	7.8	3.9	2.5	4.0	4.9	5.1	0.9	2.1	1.7	5.7	2.9	2.1	2.0	1.9	4.8	0.0	5.3	0.0	1.0	1.9	2.5	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.0	0.4	0.2	0.6	0.0	0.3	0.0	0.9	0.6	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	3.1	0.0	0.1	0.8	0.7	0.0	9.5	7.7	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.8	0.3	0.0	0.3	0.6	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	24.9	8.8	31.7	9.3	10.2	5.3	13.2	7.8	4.8	3.0	3.2	0.0	2.6	4.6	49.8	6.7	10.2	0.0	1.2	10.4	66.8	0.3	3.3	1.8	2.5	2.9	0.5	0.0	2.1	0.1	4.7	0.3	0.0	2.9	2.0	11.1	7.5	1.3	0.3	1.3	6.9	0.0	6.8	0.0	2.6	18.3	1.0	1.9	7.8	5.0	17.9	6.5	14.6	0.7	0.7	4.0	0.2	0.0	2.9	1.4
DLK1	"Delta1, FA1, pG2, Pref-1, ZOG"	ENSG00000185559	"Delta like non-canonical Notch ligand 1"	P80370	14	100725705-100738224	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 157.6;pituitary gland: 143.1;placenta: 244.9"	"Group enriched"	"Detected in many"	5	"Exocrine glandular cells: 527.9;Leydig cells: 1256.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.1"	"Group enriched"	"Detected in some"	5	"hypothalamus: 2.6;pons and medulla: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 23.1;Hep G2: 77.0;SH-SY5Y: 91.7"	"Region enhanced"	"Detected in some"		"hypothalamus: 65.4"	"Region enhanced"	"Detected in many"		"midbrain: 159.6"	"CAB005872, HPA062262"	Enhanced		Approved	"Golgi apparatus"		NA	NA		160000	"Golgi apparatus"		"CAB005872: AB_731965, HPA062262: AB_2684729"	"unprognostic (2.16e-2)"			"prognostic unfavorable (2.31e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.89e-3)"	"unprognostic (5.75e-2)"		"unprognostic (1.87e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.24e-1)"		"unprognostic (3.11e-2)"	"unprognostic (6.57e-2)"			0.3	157.6	0.2	0.7	0.8	0.0	0.9	0.0	0.1	0.5	0.0	1.8	0.2	0.2	0.2	4.4	0.3	0.3	0.8	2.7	0.1	2.6	0.1	0.1	0.1	0.1	0.8	0.0	34.9	4.6	0.0	143.1	244.9	6.0	0.2	0.0	0.2	8.2	0.0	2.0	0.1	0.2	0.2	0.3	0.2	0.2	14.2	0.0	0.5	0.0	10.0	1.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	77.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.1	6.5	91.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.8	0.0	0.0	0.1	2.6	0.8	0.0	6.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	3.2	0.0	0.0	0.0	0.0	0.0	52.1	0.0	2.9	4.0	0.0	0.0	0.0	527.9	35.4	1.3	0.5	0.0	0.0	73.1	0.0	0.0	0.0	0.0	11.5	1256.4	0.0	0.0	0.0	0.0	0.0	6.5	0.0	162.3	0.0	0.0	58.2	0.0	6.5	56.6	0.4	88.4	0.0	0.0	0.1
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490318	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 22.9;pituitary gland: 42.3"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 26.8;Cone photoreceptor cells: 33.4;Rod photoreceptor cells: 42.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.5"	"Cell line enhanced"	"Detected in many"		"AF22: 15.7;Karpas-707: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"		"HPA058676: AB_2683795, HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favorable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.9	2.3	7.3	1.3	17.6	2.6	3.4	15.8	9.9	5.4	2.0	1.1	7.6	2.6	1.8	22.9	1.1	5.7	2.1	2.0	4.2	6.8	4.0	7.2	1.9	1.5	4.4	7.5	1.2	6.3	7.2	42.3	1.0	6.3	4.3	2.6	4.6	5.9	7.3	1.1	0.8	3.8	1.2	2.1	1.7	2.7	4.8	1.4	0.0	8.7	0.2	3.3	1.9	1.1	0.6	11.5	1.4	0.3	0.1	0.5	0.2	12.3	2.6	15.7	6.1	0.4	0.0	0.4	0.1	0.6	2.4	4.6	2.4	3.6	4.7	5.7	0.1	6.5	4.1	1.7	2.5	2.4	1.9	2.9	2.2	0.2	1.3	0.3	2.7	1.6	0.2	8.4	0.6	2.6	1.1	0.0	4.0	0.8	18.1	1.0	4.1	0.3	3.7	3.4	1.6	3.6	0.1	3.7	7.2	3.3	2.1	10.2	4.3	0.4	2.5	6.8	2.9	10.9	4.6	0.5	1.3	4.8	2.8	2.2	4.0	3.5	3.9	5.3	0.6	2.8	0.5	0.3	0.1	0.2	0.2	0.5	0.4	0.4	0.3	0.9	0.6	0.2	0.3	1.4	0.1	0.2	11.5	0.3	0.2	7.3	17.6	15.8	9.9	4.2	6.8	4.4	7.5	6.3	1.4	3.0	2.6	0.0	2.3	0.1	7.9	2.0	5.1	26.8	6.8	3.5	33.4	0.5	6.6	4.5	8.6	0.0	0.0	0.0	3.9	0.2	0.9	2.7	0.0	2.4	2.0	4.8	9.8	0.6	1.0	8.4	1.1	0.0	0.0	0.0	1.9	7.8	2.9	0.0	0.7	4.0	42.0	0.0	1.2	7.4	3.4	0.0	0.0	0.0	0.8	1.0
FSHB		ENSG00000131808	"Follicle stimulating hormone beta subunit"	P01225	11	30231016-30235261	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"pituitary gland: 70.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB023410, HPA069703"	Enhanced				"Secreted to blood"	NA	NA		47000			"CAB023410: AB_324983, HPA069703: AB_2686176"												"unprognostic (1.04e-1)"						0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	70.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FST	FS	ENSG00000134363	Follistatin	P19883	5	53480409-53487134	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.7"	"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 85.9;Hepatocytes: 22.9;Urothelial cells: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.0;naive CD4 T-cell: 2.0;non-classical monocyte: 1.0"	"Group enriched"	"Detected in many"	5	"monocytes: 1.0;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 59.4;HaCaT: 50.3;HBEC3-KT: 32.1;HMC-1: 36.1;PC-3: 97.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA016612, CAB026025"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1800000	Vesicles		"CAB026025: , HPA016612: "	"unprognostic (1.43e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.44e-5)"	"unprognostic (1.21e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-1)"	12.4	3.2	2.0	3.1	0.8	0.1	7.1	0.2	0.7	3.5	5.2	0.3	1.1	0.9	2.3	9.5	3.6	4.9	4.1	5.6	1.0	1.0	1.7	42.7	4.3	0.8	0.4	0.6	20.7	19.4	0.0	2.9	13.5	1.0	9.3	1.7	5.7	5.5	6.5	12.6	9.0	4.3	3.7	0.4	0.2	4.8	4.9	0.5	1.2	2.0	6.7	7.1	6.2	13.8	0.1	0.2	0.0	1.0	0.0	2.0	0.1	3.3	0.3	5.9	0.0	6.7	2.3	9.8	13.0	59.4	8.0	7.8	0.0	0.0	0.0	0.1	3.4	0.4	50.3	0.0	32.1	5.7	0.1	0.0	0.6	0.2	5.3	3.6	0.0	36.1	5.5	0.0	14.7	9.6	5.5	6.8	0.0	0.0	0.1	5.0	0.0	0.0	0.2	9.0	0.0	97.2	0.6	7.5	0.0	0.0	5.5	0.0	0.0	0.5	0.0	0.3	15.8	0.0	0.0	0.0	22.0	6.3	2.2	1.9	0.0	0.0	0.0	2.5	0.7	20.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.1	2.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	0.8	0.2	0.7	1.0	1.0	0.4	0.6	1.0	0.5	0.0	1.4	0.0	12.8	17.7	0.0	7.3	0.0	0.0	12.5	0.0	0.0	0.6	0.0	0.6	0.3	1.6	0.0	0.0	3.8	7.6	85.9	5.3	0.0	22.9	1.6	0.0	0.0	1.3	0.3	0.9	2.8	0.4	5.0	0.0	0.0	0.0	10.0	0.0	10.6	0.0	0.0	12.9	12.5	0.3	0.7	4.1	5.0	0.0	0.0	26.0
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"pituitary gland: 149.9"	"Cell type enhanced"	"Detected in many"	10	"Ductal cells: 39.1;Exocrine glandular cells: 43.2;Extravillous trophoblasts: 33.3;Glandular cells: 54.2;Pancreatic endocrine cells: 30.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"hypothalamus: 18.8"	"Cell type enriched"	"Detected in single"	15	"intermediate monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 48.0;HEK 293: 22.4;K-562: 24.8;NB-4: 88.7;SH-SY5Y: 35.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 111.6"	"Low region specificity"	"Detected in many"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	60000		"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: AB_2680922"	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	2.8	0.2	0.1	14.8	0.5	0.4	4.5	0.6	2.0	0.2	6.0	0.1	0.4	1.7	0.2	0.7	0.7	0.2	0.3	0.6	1.3	18.8	0.3	0.2	0.2	0.1	0.2	0.6	0.2	2.9	0.0	149.9	0.9	2.2	0.7	4.1	0.6	0.5	1.8	0.3	4.5	2.2	9.7	0.3	0.2	1.5	0.5	0.4	0.7	0.2	0.4	0.3	1.5	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	4.5	6.8	0.0	0.1	0.0	48.0	1.8	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.4	1.1	14.4	0.0	0.2	0.6	0.0	0.3	0.7	0.0	0.0	0.0	1.1	0.0	24.8	0.0	0.0	13.6	0.0	88.7	11.4	0.5	4.3	0.0	0.0	9.1	0.1	0.0	9.4	35.8	4.7	0.2	0.0	5.3	0.2	10.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.7	1.3	18.8	0.2	0.6	2.2	0.4	0.0	0.0	0.0	15.3	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	39.1	0.0	0.2	0.0	0.0	43.2	33.3	2.4	54.2	4.6	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	13.7	0.4	11.4	3.0	1.6	0.0	0.6	11.9
GATA2	NFE1B	ENSG00000179348	"GATA binding protein 2"	P23769	3	128479427-128493185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Phagocytosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.2;ductus deferens: 85.8;seminal vesicle: 209.1"	"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 226.1;granulocytes: 616.3;Syncytiotrophoblasts: 268.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 36.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	339	"basophil: 81.2"	"Lineage enriched"	"Detected in single"	813	"granulocytes: 81.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 57.0;HEL: 70.3;HMC-1: 38.1;SH-SY5Y: 66.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA005633, CAB024847"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB024847: , HPA005633: AB_1078954"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.61e-2)"	"unprognostic (8.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.96e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.50e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (5.22e-5)"	7.0	6.2	2.1	1.5	2.4	2.5	7.9	1.2	1.9	22.4	2.8	1.4	85.8	2.5	20.6	5.4	3.2	23.0	9.7	4.8	1.5	1.0	7.6	0.6	16.1	2.2	1.8	1.1	4.6	5.8	3.4	4.5	51.8	2.4	27.8	1.8	6.1	1.9	209.1	3.5	4.1	3.4	8.4	1.4	5.1	2.9	2.7	1.5	0.4	3.3	2.7	1.5	22.4	12.4	0.0	0.0	81.2	0.0	0.0	0.0	0.4	4.7	1.1	0.2	3.1	0.4	0.1	57.0	10.6	9.1	3.6	1.3	1.9	2.1	0.1	3.0	6.3	0.3	5.0	2.9	0.0	1.5	0.0	1.6	70.3	7.8	3.1	0.8	7.1	38.1	0.0	0.0	0.1	0.0	0.5	5.7	0.0	18.4	0.1	0.0	1.7	0.0	14.4	0.2	0.0	0.3	0.0	1.4	0.0	0.1	4.2	4.4	66.4	2.7	14.1	0.4	3.0	2.7	2.9	10.2	0.2	0.1	2.5	1.4	0.0	0.0	0.0	0.1	0.4	0.7	81.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	2.4	1.2	1.9	1.5	1.0	1.8	1.1	2.4	1.5	6.0	48.7	0.5	16.6	4.2	0.2	6.1	0.0	1.4	3.4	71.5	0.0	50.4	1.7	0.3	5.8	56.9	0.0	0.0	12.6	226.1	5.8	36.8	616.3	0.0	9.5	0.0	2.9	34.4	0.8	4.0	0.6	2.9	8.5	0.0	0.0	0.0	1.3	0.0	0.4	0.1	0.2	0.0	7.6	0.5	2.8	2.0	268.8	0.0	0.1	10.0
GH1	"GH, GH-N, GHN, hGH-N"	ENSG00000259384	"Growth hormone 1"	P01241	17	63917200-63918838	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 994.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.1;T-reg: 2.2"	"Group enriched"	"Detected in many"	4	"B-cells: 2.1;T-cells: 2.2"	"Cell line enriched"	"Detected in some"	5	"U-698: 7.6"									HPA043715	Supported				"Secreted to blood"	NA	NA	2690000	180000			"HPA043715: AB_2678632"	"unprognostic (1.91e-2)"							"unprognostic (3.51e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.45e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-4)"	"unprognostic (2.03e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.33e-1)"		0.3	0.0	0.0	0.5	0.0	1.1	0.2	0.1	0.1	0.4	0.4	0.0	0.0	3.3	1.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.6	0.0	0.0	0.0	0.0	0.3	994.5	217.7	0.1	0.2	0.5	0.0	0.1	0.2	0.8	0.9	0.4	0.1	0.0	1.6	0.3	0.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	2.1	0.0	0.0	0.5	0.0	2.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.6	7.6	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.5	0.0	2.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0
GH2	"GH-V, GHL, GHV, hGH-V"	ENSG00000136487	"Growth hormone 2"	P01242	17	63880215-63881935	"Cancer-related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	309	"pituitary gland: 47.3;placenta: 138.4"	"Group enriched"	"Detected in some"	22	"Extravillous trophoblasts: 7.9;Syncytiotrophoblasts: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"BEWO: 13.7"									HPA043715	Supported				"Secreted to blood"	NA	NA					"HPA043715: AB_2678632"															"unprognostic (1.02e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	138.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	19.8	0.0	0.0	0.0
GNRHR	"GRHR, LHRHR"	ENSG00000109163	"Gonadotropin releasing hormone receptor"	P30968	4	67739328-67754360	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	14	"pituitary gland: 56.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"K-562: 3.0"	"Not detected"	"Not detected"							HPA013424	Enhanced					NA	NA					"HPA013424: AB_2668840"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.99e-2)"	0.1	3.9	0.1	0.4	0.2	0.2	0.1	0.3	1.7	0.3	0.1	0.1	0.1	0.7	0.1	0.1	1.6	0.0	0.2	0.2	0.2	0.2	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.3	0.0	56.6	0.1	0.5	0.2	0.0	0.1	0.3	0.1	0.2	0.9	0.1	0.1	0.1	0.2	0.3	0.3	0.1	0.2	1.0	0.1	0.4	0.1	0.5	1.3	0.2	0.0	0.0	0.4	0.3	0.0	0.2	1.5	1.5	1.6	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.5	1.7	1.3	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.3	0.5	0.3	0.3	0.7	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	1.2	3.0	0.0	0.0	0.8	0.6	0.4	1.0	0.5	0.0	0.6	1.3	0.6	0.0	0.0	0.9	2.1	0.0	0.3	0.0	0.3	0.3	0.2	1.0	0.1	0.2	0.6	0.2	1.2	0.3	0.6	1.4	0.8	0.9	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.1	0.0	0.0	1.3	0.1	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.3	0.3	0.2	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176653-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pituitary gland: 64.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 9.6;SuSa: 8.1"	"Region enriched"	"Detected in some"	6	"hypothalamus: 16.8"	"Region enriched"	"Detected in some"	9	"hypothalamus: 6.4"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	64.9	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGSF1	"IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2"	ENSG00000147255	"Immunoglobulin superfamily member 1"	Q8N6C5	X	131273506-131578899	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"pituitary gland: 138.7"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 3.0;Bipolar cells: 11.5;Horizontal cells: 3.2;Melanocytes: 3.3"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 65.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 23.5;SH-SY5Y: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012732, HPA035582"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		430000	Cytosol		"HPA012732: AB_2732404, HPA035582: AB_2674687"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (4.25e-8)"	"unprognostic (1.01e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.52e-3)"	"unprognostic (8.03e-3)"	"unprognostic (9.36e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.13e-2)"	0.8	11.9	1.4	0.4	5.3	0.0	2.7	0.6	6.2	2.7	0.5	3.3	1.2	0.2	1.1	1.5	1.3	1.6	0.8	5.6	3.3	15.4	0.5	1.5	0.2	0.0	3.8	1.9	1.0	1.7	0.0	138.7	0.6	4.7	3.9	0.2	2.2	2.0	6.4	0.3	0.6	0.4	3.2	2.7	0.2	0.5	11.8	1.9	0.2	5.3	0.8	0.5	0.6	0.5	0.6	0.4	1.5	0.3	0.3	0.3	0.2	0.3	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.2	0.0	0.0	0.0	1.3	0.0	0.0	4.1	0.3	0.0	1.7	23.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.7	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	21.2	0.0	0.2	0.0	3.2	0.4	0.0	0.0	0.3	0.6	0.0	2.4	0.7	0.3	0.0	0.0	0.0	0.0	1.5	0.3	0.2	0.2	0.1	0.2	0.3	0.3	0.3	0.1	0.6	0.3	0.2	1.2	0.3	0.1	0.4	0.3	0.2	1.4	5.3	0.6	2.3	3.3	15.4	3.8	1.9	4.7	1.9	3.0	1.1	0.0	0.2	0.0	11.5	2.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.8	0.2	0.0	0.4	0.0	3.2	0.0	1.3	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.5	0.0	0.4	0.6	0.5	0.0	0.3	0.0	0.4	0.4	0.2	0.0	0.0	0.1
LHB	"CGB4, hLHB, LSH-B"	ENSG00000104826	"Luteinizing hormone beta polypeptide"	P01229	19	49015980-49017081	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"pituitary gland: 301.4"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 2.3;Late spermatids: 3.3;Pancreatic endocrine cells: 4.8;Syncytiotrophoblasts: 8.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.8;T-reg: 1.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A549: 6.6;U-266/84: 7.1"									"CAB022241, CAB022707, HPA038925"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"CAB022241: , CAB022707: , HPA038925: AB_2676272"	"unprognostic (8.12e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.69e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.46e-1)"	"unprognostic (9.52e-2)"	"unprognostic (4.86e-2)"	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	23.1	0.0	301.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.5	0.1	0.1	0.1	0.5	1.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.1	1.3	6.6	0.3	1.3	0.0	0.0	1.8	0.5	0.0	1.0	0.5	5.4	1.9	1.8	0.1	0.0	0.3	0.5	0.0	0.4	0.0	1.7	5.2	0.3	1.7	2.5	0.3	0.4	1.8	0.0	0.0	0.3	0.0	0.0	0.3	1.1	4.8	2.9	0.3	0.4	0.1	0.6	0.7	0.3	0.5	2.8	1.2	1.3	0.0	1.4	3.0	1.2	2.0	0.4	2.2	0.0	2.0	0.0	0.0	2.7	2.8	0.3	3.3	2.5	7.1	1.8	1.4	3.1	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.3	0.0	0.0	0.0	0.7	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.5	0.0	8.6	0.0	0.0	0.1
MIA	CD-RAP	ENSG00000261857	"Melanoma inhibitory activity"	Q16674	19	40771648-40777490	"Cancer-related genes, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 16.1;breast: 28.7;pituitary gland: 33.5;salivary gland: 22.7;stomach 1: 28.9"	"Group enriched"	"Detected in some"	10	"Melanocytes: 97.8;monocytes: 52.3;Pancreatic endocrine cells: 38.8"	"Cancer enriched"	"Detected in many"	5	"melanoma: 58.6"	"Region enriched"	"Detected in some"	8	"midbrain: 16.1"	"Cell type enhanced"	"Detected in some"		"basophil: 1.6;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.0"	"Group enriched"	"Detected in some"	31	"AN3-CA: 21.8;CAPAN-2: 18.3;SK-MEL-30: 63.5;WM-115: 60.2"									HPA042369	Approved				"Secreted to blood"	NA	NA	8270000				"HPA042369: AB_10794420"	"prognostic favorable (2.08e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.02e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-1)"	"unprognostic (3.29e-8)"	"unprognostic (5.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-1)"	0.7	1.5	0.6	3.5	0.6	1.4	28.7	0.9	0.4	3.7	6.1	0.5	2.2	0.8	2.8	3.2	4.0	1.0	3.2	4.1	0.4	0.4	0.9	0.8	1.4	0.7	16.1	0.4	2.6	0.4	0.0	33.5	0.9	2.1	2.2	1.9	6.0	22.7	1.7	0.8	4.5	2.2	3.4	3.1	2.4	28.9	1.0	0.4	0.5	1.1	5.9	4.4	2.0	1.5	0.7	0.0	3.0	0.1	0.0	0.3	0.1	0.0	0.1	0.2	21.8	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.1	18.3	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	63.5	0.8	0.1	0.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	0.1	60.2	1.6	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.1	0.0	0.0	0.1	0.6	0.6	0.9	0.4	0.4	0.4	16.1	0.4	2.1	0.4	0.0	0.3	0.0	0.1	4.6	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.7	0.0	0.4	0.0	0.6	0.7	0.0	2.7	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.6	0.0	97.8	52.3	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.6	0.0	0.5	0.4
MTHFR		ENSG00000177000	"Methylenetetrahydrofolate reductase"	P42898	1	11785723-11806920	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063389, HPA076180, HPA077255"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA063389: AB_2685001, HPA076180: , HPA077255: "	"unprognostic (3.25e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.97e-5)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.69e-2)"	"prognostic favorable (4.81e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	11.7	11.0	8.9	10.3	12.4	24.5	9.7	15.3	15.8	9.0	10.4	13.5	8.3	10.7	10.4	54.5	11.3	12.7	10.9	23.4	9.2	8.6	12.0	12.4	16.2	13.3	9.9	10.7	28.8	11.2	6.7	17.5	6.6	10.7	10.2	9.1	14.1	7.3	7.2	15.3	13.2	13.6	10.9	7.4	18.3	13.6	10.6	10.9	10.2	15.8	9.8	11.7	10.4	17.9	4.9	3.2	4.7	7.4	3.4	4.7	2.3	1.3	5.9	6.8	7.8	6.8	10.5	1.1	4.2	8.8	4.0	3.5	5.4	8.7	11.4	2.3	4.3	9.3	2.6	4.8	4.0	1.7	5.4	4.4	8.4	7.4	1.5	9.1	4.6	10.9	9.2	4.0	3.0	3.3	6.6	6.2	10.8	27.4	7.5	4.1	1.8	5.0	2.2	2.3	5.9	2.1	5.2	3.7	12.6	6.4	7.2	6.8	11.6	5.2	5.1	8.2	4.3	8.1	7.2	5.5	4.0	3.3	4.7	1.0	4.2	5.7	21.3	4.9	10.6	3.6	1.1	3.8	1.9	4.7	7.4	1.8	3.0	1.6	2.5	3.2	4.9	2.4	2.7	4.7	3.4	6.9	1.5	1.0	2.3	8.9	12.4	15.3	15.8	9.2	8.6	9.9	10.7	10.7	10.9	23.8	50.3	12.3	6.7	7.4	0.0	35.5	10.2	5.3	10.3	26.2	0.0	4.1	1.7	7.7	13.8	16.2	32.7	46.7	22.0	2.7	16.0	9.3	8.1	19.5	18.8	0.0	11.6	38.6	38.0	28.3	17.0	26.2	11.8	10.8	15.4	0.0	15.7	17.8	8.5	14.3	0.0	19.4	24.7	6.0	4.7	8.2	2.4	8.7	16.5	8.1
MYO15A	"DFNB3, MYO15"	ENSG00000091536	"Myosin XVA"	Q9UKN7	17	18108706-18179806	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"pituitary gland: 46.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 72.6;Late spermatids: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.5;EFO-21: 2.7;HSkMC: 2.1;RPMI-8226: 3.2;SuSa: 3.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"hippocampal formation: 2.7"	HPA078501	Enhanced					NA	NA					"HPA078501: AB_2732383"	"unprognostic (2.48e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.33e-1)"	"unprognostic (8.32e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.18e-3)"	"unprognostic (5.69e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.21e-2)"	0.5	0.0	0.5	0.6	0.7	0.0	0.5	2.3	1.6	0.5	0.5	0.5	0.5	0.2	1.7	3.4	0.5	1.0	0.5	0.5	0.5	1.2	0.5	0.8	1.5	0.5	0.5	0.5	3.0	0.5	2.2	46.1	0.5	0.7	0.5	0.4	0.5	0.5	1.6	0.5	0.1	0.9	0.5	0.5	0.5	0.6	7.4	0.5	0.5	0.9	0.5	0.5	0.5	0.5	0.7	0.4	3.8	0.9	0.6	0.3	0.1	0.1	0.0	1.4	0.0	0.8	2.5	0.4	0.1	0.8	0.0	0.0	0.5	0.3	0.1	2.7	0.8	0.1	0.4	0.0	0.7	0.0	1.3	0.6	0.0	0.3	0.0	0.4	0.0	0.0	2.1	0.0	0.4	0.6	0.4	0.0	0.4	0.0	0.4	0.0	0.5	0.1	0.5	0.1	1.0	0.0	0.2	0.4	3.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	3.4	1.4	0.3	0.2	0.0	0.1	0.0	0.0	0.9	1.4	0.1	0.0	0.1	0.4	3.8	0.5	0.5	0.2	0.9	0.3	0.7	0.1	0.1	0.2	0.4	0.2	0.3	1.4	0.6	0.2	0.4	0.1	0.1	0.5	0.7	2.3	1.5	0.5	1.2	0.5	0.5	0.7	0.5	0.0	1.4	0.0	2.0	1.3	1.8	2.5	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.5	72.6	0.7	0.0	0.0	0.7	0.2	0.9	1.5	5.8	1.6	0.5	9.5	4.1	0.6	0.3	42.1	1.1	1.1	3.3	1.0	0.3	3.1	0.4	0.0	1.1	0.4	2.7	0.0	1.0	4.8	8.1	1.1	0.6	0.0	0.4	1.0
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934071-26212536	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.1;testis: 12.5"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 127.9;Late spermatids: 34.5;Muller glia cells: 68.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4"	"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.7;SCLC-21H: 2.5;U-2 OS: 4.4;U-698: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No			"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.8	0.7	0.4	0.3	5.0	0.5	1.5	0.3	1.9	2.1	0.6	0.1	0.7	0.4	0.3	3.2	0.9	1.1	0.3	0.3	0.5	1.3	0.9	0.2	1.0	0.3	0.2	0.0	0.5	2.1	0.2	8.1	0.2	5.4	0.5	1.1	3.8	0.2	0.6	0.3	2.2	0.6	1.0	0.4	0.3	0.9	12.5	0.8	0.0	1.3	1.4	0.9	0.5	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	1.5	0.0	0.0	1.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.3	1.9	0.5	1.3	0.2	0.0	5.4	0.8	0.0	0.3	0.0	0.3	1.5	0.9	0.6	0.0	0.0	4.5	0.0	0.0	0.0	1.7	0.5	127.9	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	34.5	1.1	0.0	0.0	0.0	0.2	68.5	0.3	0.0	1.1	1.4	3.4	0.0	0.0	20.0	5.8	0.9	0.0	0.0	0.0	0.1
NEUROD4	"ATH-3, Atoh3, bHLHa4, MATH-3"	ENSG00000123307	"Neuronal differentiation 4"	Q9HD90	12	55019945-55030014	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"pituitary gland: 54.8"	"Cell type enriched"	"Detected in some"	16	"Bipolar cells: 170.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 3.7;SCLC-21H: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015545	Enhanced					NA	NA					"HPA015545: AB_2669215"					"unprognostic (1.78e-2)"													0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	54.8	0.0	0.7	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	170.1	2.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NME7	"CFAP67, FLJ37194, NM23-H7"	ENSG00000143156	"NME/NM23 family member 7"	Q9Y5B8	1	169132531-169367967	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038014, HPA054289"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038014: AB_10673037, HPA054289: AB_2682437"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.44e-3)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.74e-1)"	7.7	12.1	13.5	8.0	22.8	3.7	12.8	14.6	16.8	15.6	11.5	5.5	13.4	4.6	16.0	15.8	8.6	31.1	11.2	8.4	18.9	11.3	13.9	8.6	8.9	6.0	9.5	11.5	17.0	8.1	18.9	39.9	5.6	15.6	9.6	6.7	9.3	5.9	14.3	5.1	4.9	5.5	17.2	9.5	5.2	8.1	17.2	9.6	11.9	15.9	5.8	7.0	10.0	8.2	8.5	5.2	1.7	7.1	9.1	12.0	4.7	10.5	11.3	12.3	9.6	12.4	12.5	4.4	7.3	11.1	13.3	16.9	6.4	16.0	3.1	13.4	6.5	18.4	7.4	6.9	15.8	21.8	11.0	5.7	5.6	10.8	6.5	8.5	10.2	3.6	9.1	9.6	13.4	18.2	19.2	19.0	9.6	5.3	4.3	13.3	3.4	9.2	7.5	12.1	12.7	11.6	7.2	13.3	6.8	21.6	3.1	13.3	19.2	11.1	3.3	8.2	14.4	11.4	7.4	11.4	8.3	27.5	7.3	17.7	5.2	8.8	6.5	9.1	3.6	8.2	1.4	3.3	1.7	8.3	5.1	10.1	8.5	10.8	8.8	5.2	7.0	9.3	10.6	1.0	9.1	7.1	4.4	12.0	4.7	13.5	22.8	14.6	16.8	18.9	11.3	9.5	11.5	15.6	9.6	6.0	7.5	8.2	29.3	12.8	17.2	4.1	15.3	72.3	15.9	26.2	23.6	6.8	19.9	22.8	19.4	13.7	2.6	0.0	7.9	6.3	18.5	7.6	20.8	10.4	12.0	27.0	16.8	11.1	4.0	7.9	16.7	8.2	8.5	2.8	3.9	18.0	13.9	6.0	19.4	30.7	61.3	19.4	17.5	51.2	20.0	8.9	2.3	14.1	6.6	17.3
NPHP1	"JBTS4, NPH1, SLSN1"	ENSG00000144061	"Nephrocystin 1"	O15259	2	110122311-110205066	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"		"Ciliopathy, Disease mutation, Joubert syndrome, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 36.7"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 172.6;Early spermatids: 98.9;Rod photoreceptor cells: 72.4;Spermatocytes: 129.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046093, HPA074071"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA046093: AB_2679535, HPA074071: "	"unprognostic (2.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.66e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.93e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.64e-2)"	3.1	4.3	8.5	1.8	13.7	0.8	5.1	2.1	7.2	5.6	4.7	4.9	8.8	1.7	7.2	11.3	2.1	19.3	4.3	4.4	9.0	7.5	8.7	1.5	5.7	1.5	3.8	6.2	5.4	3.5	17.7	28.1	2.1	20.3	4.4	2.6	4.6	2.8	8.9	36.7	1.7	1.8	7.2	5.4	1.9	3.7	25.0	7.2	0.0	8.9	3.2	1.3	4.1	3.7	3.5	1.0	1.0	0.3	3.2	1.8	0.7	8.5	2.7	5.7	4.2	3.2	6.8	1.2	2.2	7.1	7.7	7.6	2.8	6.4	0.5	5.7	5.1	7.3	4.2	2.7	6.9	9.2	1.6	3.4	0.2	1.6	1.9	4.5	1.3	0.0	4.6	4.2	12.0	3.8	11.6	4.8	1.8	0.1	0.8	4.6	1.7	0.8	2.1	2.5	0.2	4.5	0.0	5.9	0.2	13.0	0.7	3.0	3.1	3.2	3.9	7.8	2.9	4.6	1.0	3.1	4.5	3.8	4.9	7.0	2.4	2.5	0.6	13.1	0.2	3.2	0.7	0.1	0.1	1.2	0.3	1.8	2.7	0.9	0.6	1.0	3.5	1.8	1.4	1.0	3.2	0.1	0.1	0.1	0.7	8.5	13.7	2.1	7.2	9.0	7.5	3.8	6.2	20.3	7.2	6.0	6.2	0.9	7.4	4.6	11.8	11.8	7.6	172.6	30.7	8.7	45.2	1.5	16.6	12.1	98.9	6.7	0.0	0.0	4.4	0.4	4.6	3.5	0.0	2.4	1.3	20.6	0.0	7.4	1.0	44.3	6.9	2.3	6.8	0.0	0.5	10.9	6.3	0.2	9.2	21.1	72.4	12.9	3.9	129.6	24.9	3.4	0.2	1.0	1.8	4.7
NPTX2		ENSG00000106236	"Neuronal pentraxin 2"	P47972	7	98617297-98629868	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7"	"Group enriched"	"Detected in many"	6	"Peritubular cells: 306.6;Sertoli cells: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Cell line enriched"	"Detected in some"	12	"LHCN-M2: 128.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020801, HPA049799, HPA058320"	Enhanced		Approved	"Golgi apparatus,Actin filaments,Centrosome"	"Secreted to blood"	NA	NA	2490000	320000	"Golgi apparatus, Actin filaments"	Centrosome	"CAB020801: , HPA049799: AB_2680889, HPA058320: AB_2732621"	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (1.91e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (5.46e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.69e-2)"	4.3	24.0	7.1	2.3	8.4	1.0	1.4	0.2	45.6	8.2	3.8	3.2	0.1	1.1	1.8	3.9	2.2	1.5	1.6	3.2	9.2	11.0	0.9	0.9	0.8	0.7	9.4	2.2	1.5	19.5	0.8	71.6	0.8	7.0	2.1	1.4	1.3	1.5	2.2	2.9	4.0	1.3	2.9	2.9	6.1	1.9	20.7	5.0	0.0	1.6	0.1	0.9	1.4	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.7	0.0	0.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	6.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	7.1	8.4	0.2	24.6	9.2	11.0	9.4	2.2	7.0	5.0	0.0	1.1	0.0	0.4	3.4	17.7	2.8	5.1	0.0	2.3	0.0	3.9	0.0	0.0	5.8	9.7	2.9	2.4	0.0	11.0	0.2	6.2	3.2	0.0	0.2	0.4	0.0	15.3	6.2	0.0	19.9	13.0	0.0	11.8	0.0	0.0	0.8	4.7	0.0	306.6	0.0	2.4	148.8	3.8	14.0	40.1	2.6	0.1	0.0	0.4	0.5
NPW	PPL8	ENSG00000183971	"Neuropeptide W"	Q8N729	16	2009926-2020755	"Predicted intracellular proteins, Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"liver: 49.0;placenta: 17.7"	"Cell type enriched"	"Detected in many"	5	"Intestinal endocrine cells: 152.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"NB-4: 17.1;PC-3: 9.5;RPMI-8226: 29.9;SCLC-21H: 52.0"	"Low region specificity"	"Detected in single"							HPA064874	Approved				"Secreted to blood"	NA	NA					"HPA064874: AB_2685378"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.81e-5)"	"unprognostic (6.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.41e-1)"	"unprognostic (3.43e-2)"	0.9	0.6	0.6	1.3	0.8	2.3	0.4	0.6	1.6	1.6	1.3	0.0	3.1	1.4	5.9	3.0	0.9	1.1	0.7	0.3	0.5	0.9	1.0	49.0	0.4	1.3	0.4	0.7	1.0	2.0	0.3	5.9	17.7	1.2	1.5	0.7	1.1	0.5	3.4	0.3	2.3	0.7	0.6	0.5	2.8	6.0	4.3	0.4	3.7	0.8	0.9	1.0	0.6	1.3	1.6	2.0	4.7	2.1	1.6	1.8	0.6	0.1	0.8	0.1	1.1	0.1	0.0	0.2	0.3	0.1	0.2	0.4	1.9	0.6	0.2	0.0	0.3	0.2	0.3	0.5	0.2	0.2	0.7	1.0	0.0	1.2	0.6	0.8	0.1	0.0	0.5	0.5	0.3	0.8	0.0	0.0	0.9	2.9	0.6	0.0	0.5	0.1	17.1	0.7	0.6	9.5	3.3	0.0	29.9	0.1	0.0	52.0	4.2	0.4	0.9	0.1	0.2	2.2	1.4	0.6	0.1	0.2	0.1	0.0	1.4	0.4	0.4	0.2	0.4	0.1	3.6	2.1	1.9	0.6	1.3	1.8	1.4	0.3	0.2	2.0	1.6	0.9	0.3	4.7	1.6	0.6	1.1	1.1	0.6	0.6	0.8	0.6	1.6	0.5	0.9	0.4	0.7	1.2	0.4	0.0	0.0	1.9	2.8	1.8	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.6	0.1	2.6	0.0	0.2	0.6	0.8	6.4	9.2	30.0	2.1	0.0	152.5	0.6	0.3	1.7	2.0	0.1	3.3	0.0	23.4	0.0	2.2	3.6	2.1	0.5	0.3	0.0	1.0	3.8	26.6	1.9	1.4	0.8	3.0	3.2
PCSK1N	"BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII"	ENSG00000102109	"Proprotein convertase subtilisin/kexin type 1 inhibitor"	Q9UHG2	X	48831094-48835633	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.9;kidney: 72.9;pituitary gland: 127.7"	"Group enriched"	"Detected in many"	5	"Intestinal endocrine cells: 2932.5;Proximal tubular cells: 1024.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	77	"T-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 20.0;PC-3: 50.7;SCLC-21H: 20.1;SH-SY5Y: 18.6;SiHa: 17.6;U-266/84: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003925, HPA064734"	Enhanced	Supported	Approved	Vesicles	"Secreted to blood"	NA	NA		5300000	Vesicles		"HPA003925: AB_1079582, HPA064734: AB_2685339"	"unprognostic (2.44e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (3.36e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.79e-3)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	4.1	27.5	49.1	2.6	72.7	2.1	2.2	15.6	70.3	3.2	9.8	10.8	1.5	12.4	4.4	10.9	2.1	2.3	2.8	2.7	38.5	74.9	72.9	2.1	2.6	2.2	33.5	29.0	2.2	20.0	12.4	127.7	2.3	32.9	4.6	2.7	6.6	2.8	3.1	2.2	2.8	8.5	2.7	18.3	2.4	26.0	3.8	9.8	0.0	2.2	0.0	2.1	2.1	0.5	0.1	0.0	0.0	0.0	0.0	8.2	0.8	0.0	1.8	0.0	5.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.6	0.0	1.4	0.2	0.0	0.3	0.0	0.0	20.0	0.0	0.0	3.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	2.7	0.0	50.7	0.0	0.0	0.1	0.4	0.0	20.1	18.6	17.6	0.0	1.4	0.2	0.0	0.0	0.0	0.0	7.8	0.0	1.6	4.6	23.4	0.1	0.1	0.0	0.5	0.0	0.0	0.0	1.1	0.0	3.0	0.0	6.5	6.3	0.0	0.1	2.7	8.2	0.0	0.0	0.0	0.0	2.1	0.8	49.1	72.7	15.6	70.3	38.5	74.9	33.5	29.0	32.9	9.8	0.0	0.0	2.2	1.5	14.1	134.7	1.0	5.1	1.4	0.0	369.9	49.1	0.5	235.4	7.5	11.6	0.5	12.9	0.0	0.6	43.5	6.2	36.6	0.0	0.0	1.5	413.2	2932.5	0.0	0.0	41.9	3.1	2.7	54.0	0.0	16.6	54.9	36.6	411.7	6.7	1024.2	101.7	0.0	16.5	18.2	20.6	10.0	1.6	3.2	10.1	2.6
PEX5L	"PEX5R, PXR2, TRIP8b"	ENSG00000114757	"Peroxisomal biogenesis factor 5 like"	Q8IYB4	3	179794958-180037053	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 41.9;parathyroid gland: 60.1"	"Cell type enriched"	"Detected in some"	10	"Cone photoreceptor cells: 237.6"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 5.8;MOLT-4: 20.2;RPMI-8226: 16.1;SCLC-21H: 9.9;U-266/70: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058026	Enhanced					NA	NA					"HPA058026: AB_2683582"	"unprognostic (5.21e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.67e-5)"	"unprognostic (3.84e-1)"	"unprognostic (2.66e-10)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.03e-3)"	1.3	1.4	17.0	1.3	26.6	1.2	1.2	1.8	41.9	1.3	1.2	24.5	0.0	1.3	1.2	1.5	1.3	1.4	1.2	1.3	16.9	8.1	1.3	1.2	1.3	1.2	38.4	18.9	2.9	10.6	60.1	5.3	1.1	24.1	1.4	1.2	0.0	1.3	1.2	1.4	1.2	1.3	1.1	32.3	1.2	1.3	5.4	36.5	0.0	1.3	0.0	1.2	1.2	0.4	0.8	0.4	0.8	0.1	0.4	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	5.8	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.1	0.0	0.0	1.0	0.5	0.0	0.5	0.0	2.9	0.0	0.0	20.2	0.0	1.2	0.0	0.2	0.1	0.0	16.1	0.0	0.0	9.9	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.1	0.1	0.0	0.5	13.0	0.4	0.0	0.3	0.1	0.5	0.6	0.1	0.2	0.6	0.1	0.5	0.0	0.1	0.0	0.0	0.8	0.2	0.3	0.8	0.4	0.1	0.4	0.0	0.0	17.0	26.6	1.8	26.0	16.9	8.1	38.4	18.9	24.1	36.5	0.0	0.0	0.0	0.2	0.0	6.9	2.8	0.0	0.0	0.0	0.0	237.6	0.0	0.0	0.0	23.1	0.4	0.0	0.0	0.5	0.0	0.2	0.3	0.0	0.0	0.1	9.5	0.0	0.0	0.0	15.4	0.3	0.0	0.0	1.0	0.0	2.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.7	0.9	0.3	0.0	0.0	0.0	0.0
POMC	"ACTH, CLIP, LPH, MSH, NPP, POC"	ENSG00000115138	Proopiomelanocortin	P01189	2	25160853-25168903	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Endorphin, Hormone"	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"pituitary gland: 811.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 92.7;Late spermatids: 265.2;Spermatocytes: 70.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 18.5"	"Region enriched"	"Detected in single"	5	"hypothalamus: 1.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.7;HMC-1: 4.2;HSkMC: 1.2;NTERA-2: 1.2;THP-1: 5.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hypothalamus: 77.9"	"CAB002762, HPA046135, HPA063644, CAB079881"	Enhanced				"Secreted to blood"	NA	NA	380000				"CAB002762: , CAB079881: , HPA046135: AB_2679552, HPA063644: AB_2685071"	"unprognostic (8.02e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.84e-2)"	1.0	3.2	0.3	0.8	0.3	0.5	0.3	0.3	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	0.3	0.0	0.3	0.3	0.3	1.8	0.5	0.3	0.3	0.6	0.3	0.3	0.3	22.2	0.0	811.1	0.9	0.3	0.3	0.0	0.3	0.4	0.3	3.6	0.9	0.3	0.3	0.3	1.3	0.4	2.9	0.3	0.3	0.3	0.4	0.3	0.3	0.3	13.7	22.2	6.6	10.1	12.6	10.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	4.2	1.2	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	9.9	6.6	9.8	10.1	7.7	12.8	7.5	9.3	12.5	13.7	9.9	10.5	3.1	12.6	5.9	22.2	7.9	7.6	0.3	0.3	0.3	0.3	0.3	1.8	0.3	0.3	0.3	0.3	0.0	2.1	11.0	1.4	3.9	1.8	2.6	0.0	0.0	1.2	0.0	0.0	0.3	13.3	7.0	92.7	6.9	0.0	0.0	14.7	5.6	3.3	3.9	6.9	1.3	29.5	6.4	0.0	9.8	6.3	265.2	4.4	7.2	16.9	8.2	0.0	4.1	9.1	0.0	12.4	2.1	7.1	12.9	3.1	70.4	22.9	4.8	0.3	8.7	0.0	3.0
POU1F1	"GHF-1, PIT1, POU1F1a"	ENSG00000064835	"POU class 1 homeobox 1"	P28069	3	87259404-87276587	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"pituitary gland: 138.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.8;SiHa: 1.1;U-87 MG: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041646, HPA050624"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041646: AB_10794672, HPA050624: AB_2681192"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-2)"		"unprognostic (1.22e-1)"	"unprognostic (1.05e-4)"	0.3	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	138.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.8	0.3	0.1	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	1.1	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.7	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PRL		ENSG00000172179	Prolactin	P01236	6	22287244-22297501	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	Lactation	Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"pituitary gland: 1739.5"	"Group enriched"	"Detected in some"	7	"Early spermatids: 11.3;Late spermatids: 17.4;Rod photoreceptor cells: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.2;non-classical monocyte: 1.0"	"Group enriched"	"Detected in many"	12	"monocytes: 1.0;T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.0;SCLC-21H: 6.7;U-937: 3.2"					"Not detected"	"Not detected"			"CAB023353, HPA042416, HPA062017"	Enhanced				"Secreted to blood"	NA	NA	53900000	3300000			"CAB023353: AB_617369, HPA042416: AB_2677987, HPA062017: AB_2684660"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (5.89e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.87e-1)"			"unprognostic (1.11e-4)"	"unprognostic (4.54e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.79e-2)"			"unprognostic (4.29e-5)"	"unprognostic (2.20e-1)"			0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1739.5	21.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.3	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	17.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PRLHR	"GPR10, PrRPR"	ENSG00000119973	"Prolactin releasing hormone receptor"	P49683	10	118589989-118595699	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 11.3;brain: 10.6;cervix, uterine: 8.3;pituitary gland: 11.8;smooth muscle: 8.1"	"Cell type enriched"	"Detected in single"	15	"Horizontal cells: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	4	"SH-SY5Y: 3.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA039361	Enhanced					NA	NA					"HPA039361: AB_10673527"					"unprognostic (1.83e-1)"						"unprognostic (2.62e-3)"	"unprognostic (1.22e-1)"		"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"		0.2	11.3	1.4	0.2	3.0	0.2	0.1	3.2	5.1	8.3	0.2	0.8	0.0	0.3	5.4	0.2	0.2	0.4	0.2	0.1	0.6	4.0	0.1	0.2	0.2	0.1	3.4	0.9	0.1	0.5	0.1	11.8	0.1	10.6	0.3	0.2	0.1	0.2	1.4	0.2	0.2	0.2	8.1	0.5	0.2	0.5	0.2	1.0	0.0	0.2	0.0	0.1	0.1	5.4	0.5	0.4	1.3	0.3	0.7	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.5	0.3	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.5	0.3	0.2	1.3	0.7	0.3	0.4	0.0	0.0	1.4	3.0	3.2	1.9	0.6	4.0	3.4	0.9	10.6	1.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PROP1		ENSG00000175325	"PROP paired-like homeobox 1"	O75360	5	177992235-177996242	"Disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	8	"pituitary gland: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049839	Enhanced					NA	NA					"HPA049839: AB_2732557"										"unprognostic (2.90e-1)"		"unprognostic (4.90e-1)"		"unprognostic (2.13e-2)"				0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	4.7	0.0		0.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343865	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 160.7"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 182.0;Extravillous trophoblasts: 368.5;Fibroblasts: 184.0;Horizontal cells: 497.4;Leydig cells: 159.9;Muller glia cells: 523.9;Peritubular cells: 174.3;Syncytiotrophoblasts: 161.7"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"AF22: 190.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	167000	1800000	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	7.8	6.6	55.5	2.0	43.3	0.9	27.7	38.6	58.5	30.7	7.2	26.9	9.9	2.5	25.2	18.7	25.0	7.2	18.2	29.4	42.3	29.7	12.7	3.4	6.5	2.6	31.6	27.0	7.2	3.4	160.7	52.5	11.8	31.4	38.5	7.7	19.0	12.0	18.1	1.5	3.6	4.0	17.7	23.4	12.4	5.4	16.8	23.3	1.3	5.1	8.7	5.3	7.7	18.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	190.8	2.3	0.0	0.1	15.6	4.9	14.6	2.7	3.8	0.0	0.0	0.0	0.0	6.4	1.7	0.1	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	1.8	0.0	2.7	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	14.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.9	13.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	4.2	3.7	0.2	10.6	0.0	0.0	0.0	13.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	43.3	38.6	42.0	42.3	29.7	31.6	27.0	31.4	23.3	0.0	0.0	0.0	1.3	20.6	19.5	14.2	0.0	2.7	4.5	1.8	5.9	182.0	8.3	1.2	11.9	8.4	0.0	0.0	0.0	368.5	184.0	17.1	0.0	0.0	18.1	497.4	0.0	8.6	0.3	8.3	159.9	1.4	42.2	0.0	0.0	523.9	0.2	0.0	174.3	5.1	27.0	58.2	33.4	1.8	1.5	12.2	161.7	0.0	0.0	2.0
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase, receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Receptor	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.6;pancreas: 28.9;pituitary gland: 43.4"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 48.9;Cone photoreceptor cells: 56.9;Horizontal cells: 92.2;Intestinal endocrine cells: 45.2;Rod photoreceptor cells: 31.1"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-2 OS: 20.3;U-87 MG: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007152: AB_2667759, HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"	1.7	22.3	19.3	4.7	35.7	1.7	1.3	17.3	89.6	1.2	2.4	2.5	0.0	2.5	1.5	1.2	1.5	1.3	1.5	1.4	21.6	40.1	1.5	1.2	1.4	1.3	14.4	19.8	1.3	28.9	1.2	43.4	1.4	22.0	1.4	1.9	3.1	1.2	1.3	1.2	2.0	2.5	2.4	3.5	1.3	6.0	1.4	2.1	0.0	1.5	0.0	1.2	2.7	0.0	0.1	0.3	0.2	0.0	0.0	0.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.3	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.1	2.5	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	3.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.2	75.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	3.7	19.3	35.7	17.3	54.0	21.6	40.1	14.4	19.8	22.0	2.1	0.0	0.0	0.0	0.1	0.1	48.9	1.7	0.0	0.0	0.0	0.0	56.9	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	92.2	45.2	0.0	0.0	0.2	0.3	0.0	1.7	0.0	0.0	4.1	4.3	0.0	0.0	0.0	31.1	0.0	0.3	2.2	2.3	0.1	0.0	0.0	0.0	0.0
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase, receptor type N2"	Q92932	7	157539056-158587788	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6;pancreas: 51.3"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 84.3;Intestinal endocrine cells: 126.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 14.8"	"Cell line enhanced"	"Detected in some"		"AF22: 15.6;HDLM-2: 22.0;NB-4: 22.6;SCLC-21H: 12.5;SH-SY5Y: 12.7;THP-1: 11.1;U-87 MG: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	2.1	10.5	20.1	1.7	33.9	1.0	1.1	6.2	40.6	1.7	4.6	2.9	0.0	5.1	2.0	2.9	1.5	6.9	4.7	1.9	18.2	21.3	2.0	1.2	3.1	2.1	11.3	22.3	5.8	51.3	0.5	20.0	1.5	10.3	10.2	3.7	1.5	3.4	2.6	0.8	0.7	4.2	1.6	5.3	7.7	24.2	2.2	5.2	0.0	5.6	0.3	1.7	2.8	0.6	3.4	1.3	14.8	1.1	1.5	3.5	1.1	0.0	0.2	15.6	1.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.6	0.2	3.7	0.0	0.4	0.0	0.0	22.0	0.2	0.0	0.0	2.5	0.6	0.0	0.0	1.1	0.2	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.0	0.2	6.5	22.6	3.1	5.5	0.8	0.0	0.7	0.1	0.0	0.0	12.5	12.7	0.0	0.0	0.0	0.0	0.0	11.1	3.3	5.1	1.9	0.0	0.4	0.1	0.0	0.0	15.4	9.2	3.7	8.7	1.1	1.6	0.9	0.1	0.3	2.3	1.5	1.1	1.3	3.4	1.4	0.9	14.8	1.5	0.0	0.2	3.5	1.1	20.1	33.9	6.2	40.6	18.2	21.3	11.3	22.3	10.3	5.2	3.0	11.7	10.4	12.5	2.1	31.6	2.2	7.6	84.3	13.6	38.4	9.8	0.4	29.9	15.8	35.1	23.3	4.5	0.0	11.7	0.4	3.9	21.1	18.5	0.8	34.3	11.1	126.1	41.1	11.0	13.1	11.5	6.0	11.8	3.6	39.6	40.1	6.1	5.8	18.4	3.5	6.3	25.8	5.1	41.6	11.7	1.3	0.6	10.0	7.2	22.5
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37344574-37373322	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.6;blood: 137.6"	"Group enriched"	"Detected in many"	6	"Intestinal endocrine cells: 208.4;Melanocytes: 501.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 137.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 137.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.9;SCLC-21H: 24.3;SK-MEL-30: 81.6;U-266/84: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	3.2	77.6	4.3	5.4	5.8	17.0	6.4	1.2	11.6	9.2	11.3	2.2	1.5	2.2	6.2	43.7	2.4	1.9	5.5	2.9	6.7	17.9	12.4	1.3	6.1	7.4	3.9	5.0	1.4	5.5	9.6	31.6	7.8	5.9	3.5	4.2	21.2	14.7	2.8	4.0	14.2	2.3	3.4	3.0	8.5	3.4	2.6	0.5	2.3	1.8	4.4	4.8	7.0	2.9	0.2	10.7	137.6	29.7	0.0	0.0	12.1	0.1	8.0	0.0	0.0	1.1	2.7	0.0	1.1	17.9	1.3	2.1	0.5	1.4	0.0	0.6	6.0	15.2	0.0	0.5	0.0	2.1	0.1	15.6	3.6	0.0	1.5	0.1	0.5	0.0	1.5	0.0	9.9	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	8.8	2.2	24.3	0.0	1.3	0.0	81.6	1.6	0.1	0.6	3.8	0.0	0.0	0.0	0.1	3.1	63.8	0.0	5.5	0.0	0.0	0.6	29.7	0.2	0.0	3.4	0.0	0.2	0.0	0.0	10.7	0.1	0.0	0.0	137.6	0.0	0.3	0.2	0.0	12.1	4.3	5.8	1.2	11.6	6.7	17.9	3.9	5.0	5.9	0.5	3.0	2.9	8.2	9.7	34.7	10.9	1.1	2.5	1.4	0.0	21.0	2.0	0.5	1.7	45.4	0.4	7.3	2.0	0.0	2.1	4.3	11.0	9.5	55.3	0.2	21.3	41.3	208.4	22.7	29.2	2.2	2.8	35.6	501.0	10.8	5.8	1.2	25.4	1.9	22.3	4.7	2.9	12.9	15.5	2.1	0.6	12.7	3.9	1.9	6.9	5.5
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602503	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 124.4;Intestinal endocrine cells: 272.8"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 25.5;HSkMC: 21.8;hTERT-RPE1: 21.8;SCLC-21H: 22.2;SH-SY5Y: 9.7;WM-115: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		54000	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	3.5	133.0	13.3	11.0	94.1	0.9	0.9	5.6	55.9	1.4	5.4	5.8	0.0	17.3	2.1	0.9	1.0	0.8	2.2	1.4	10.5	79.4	1.0	0.8	1.9	0.9	21.7	11.0	1.3	10.7	1.1	76.5	1.1	57.7	2.1	5.5	1.5	0.9	1.3	0.8	1.0	8.0	5.2	10.3	0.8	8.0	0.9	5.0	0.0	3.1	0.0	0.8	1.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.8	4.0	1.1	25.5	0.1	0.2	0.9	1.8	4.7	0.2	0.4	0.0	0.4	0.3	2.9	0.1	0.1	0.0	2.4	0.0	0.2	0.0	0.2	0.0	0.3	0.3	2.1	21.8	0.1	2.7	0.9	21.8	0.0	0.0	0.1	0.2	2.3	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	22.2	9.7	0.0	0.2	1.1	0.8	0.0	0.0	0.0	2.5	1.0	0.1	1.6	0.0	0.0	0.1	0.7	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	13.3	94.1	5.6	23.0	10.5	79.4	21.7	11.0	57.7	5.0	6.0	0.0	0.0	0.2	0.0	124.4	0.2	0.0	1.4	2.3	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.9	0.0	0.0	0.1	7.9	272.8	1.3	0.8	0.0	0.6	0.0	1.7	0.0	0.7	11.9	24.2	2.9	0.4	0.0	12.7	0.0	0.5	0.1	0.2	0.1	0.1	0.0	0.3	0.6
SCG5	"7B2, SGNE1, SgV"	ENSG00000166922	"Secretogranin V"	P05408	15	32641676-32697098	"Predicted secreted proteins"	Transport	"Chaperone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.1;pancreas: 63.5;parathyroid gland: 60.1;pituitary gland: 74.6"	"Cell type enriched"	"Detected in many"	6	"Intestinal endocrine cells: 452.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 82.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 2.8;naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"HHSteC: 15.0;HSkMC: 18.6;NTERA-2: 8.4;SCLC-21H: 17.2;SH-SY5Y: 19.9;U-87 MG: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013136, HPA074618"	Enhanced				"Secreted to blood"	NA	NA		22000			"HPA013136: AB_1856657, HPA074618: AB_2732262"	"unprognostic (1.71e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-3)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (4.51e-9)"	"unprognostic (3.57e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (8.88e-2)"	1.2	30.7	24.0	2.2	47.2	0.9	2.5	36.4	71.1	1.0	4.4	13.0	0.0	9.0	3.4	21.8	1.0	2.4	3.4	1.0	30.5	36.9	1.2	2.2	2.5	1.3	25.2	23.1	2.0	63.5	60.1	74.6	0.9	30.5	3.2	5.5	15.4	0.7	1.2	0.7	1.3	3.3	3.9	24.1	1.0	21.0	3.0	9.5	0.0	1.8	0.0	0.9	2.5	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.2	0.1	0.1	0.1	0.3	2.5	0.0	2.2	0.2	0.2	0.2	0.1	0.0	0.2	1.1	0.2	0.9	0.6	0.3	0.1	0.6	0.3	0.1	0.3	0.0	0.0	15.0	0.1	0.4	18.6	0.1	0.4	0.2	0.5	0.3	0.5	0.1	0.3	0.4	0.0	0.1	0.2	8.4	0.0	0.4	0.0	0.2	0.3	0.2	0.0	17.2	19.9	0.1	0.0	0.1	0.2	0.0	0.2	0.0	2.9	1.9	0.1	0.2	0.3	1.2	0.2	26.1	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	24.0	47.2	36.4	50.8	30.5	36.9	25.2	23.1	30.5	9.5	0.0	0.3	0.0	0.2	0.6	53.1	0.3	0.0	0.0	4.5	0.0	2.0	0.1	0.0	0.5	43.4	0.1	0.4	0.0	71.7	0.2	2.6	1.8	2.3	13.0	6.3	47.7	452.1	0.6	1.2	72.8	2.0	1.2	3.3	1.0	3.1	11.2	35.0	0.0	7.4	0.0	20.6	0.0	0.4	6.4	0.9	0.3	0.2	0.0	0.7	0.1
SIX6	"OPTX2, Six9"	ENSG00000184302	"SIX homeobox 6"	O95475	14	60508951-60512850	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cataract, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pituitary gland: 43.3"	"Cell type enhanced"	"Detected in some"	33	"Cone photoreceptor cells: 27.5;Horizontal cells: 46.1;Muller glia cells: 158.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.0"	"Region enriched"	"Detected in single"	8	"hypothalamus: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"JURKAT: 9.3;MOLT-4: 29.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"hypothalamus: 2.5"	HPA001403	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001403: AB_1079993"					"unprognostic (2.76e-1)"				"unprognostic (6.14e-2)"			"unprognostic (8.18e-2)"			"unprognostic (5.75e-2)"			0.1	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.4	0.0	10.6	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	29.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.8	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	158.1	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBX19	"dj747L4.1, TPIT"	ENSG00000143178	"T-box 19"	O60806	1	168281040-168314426	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"pituitary gland: 50.4"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 9.4;HDLM-2: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005800, HPA072686"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA005800: AB_1080219, HPA072686: AB_2732209"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.36e-2)"	"unprognostic (7.14e-7)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (8.57e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	1.0	0.4	1.0	1.0	1.0	0.5	2.5	1.0	1.0	1.5	1.3	1.0	1.0	0.8	5.3	1.0	1.1	2.0	1.4	1.0	1.0	0.8	1.0	1.0	2.2	2.1	1.0	1.0	2.9	1.0	0.2	50.4	1.0	1.0	1.2	1.1	1.0	2.2	1.4	1.0	1.9	1.0	3.6	1.0	2.1	0.6	1.0	1.0	1.0	1.0	1.0	1.3	1.3	1.2	1.6	6.3	2.7	2.4	2.6	3.1	1.3	1.6	0.1	1.4	5.3	2.5	1.2	1.7	2.9	1.5	1.0	1.6	2.4	1.7	1.5	2.9	1.1	1.5	9.4	0.8	0.7	1.4	8.1	1.4	0.3	1.7	0.7	2.9	2.6	3.6	2.2	2.6	0.3	1.5	2.6	1.2	0.6	1.8	2.4	1.3	0.3	1.4	2.4	0.4	5.6	1.0	2.2	0.7	0.5	2.3	0.7	1.9	2.8	1.6	1.2	1.6	2.4	0.4	2.2	2.1	1.0	2.4	2.0	2.9	1.6	1.3	1.2	0.2	0.8	2.8	0.5	1.8	0.8	3.1	1.3	1.4	1.2	2.2	2.0	1.8	1.6	1.5	1.3	2.7	2.6	2.4	6.3	2.0	1.3	1.0	1.0	1.0	1.0	1.0	0.8	1.0	1.0	1.0	1.0	0.0	0.3	0.0	1.1	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.5	2.7	0.9	0.0	0.3	0.2	2.3	3.4	4.6	0.5	1.1	0.0	1.2	0.0	2.1	0.4	3.1	2.8	0.0	2.8	0.7	0.8	1.4	0.0	2.5	0.3	0.0	0.0	0.8	0.5	0.7	2.9	0.1	1.8	0.8	2.0
TGFBR3L		ENSG00000260001	"Transforming growth factor beta receptor 3 like"	H3BV60	19	7916145-7919097	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"pituitary gland: 56.6"	"Cell type enhanced"	"Detected in many"	10	"Sertoli cells: 12.9;T-cells: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"PC-3: 5.7;REH: 13.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA074356	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA074356: AB_2686681"	"unprognostic (1.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.65e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.62e-3)"	0.3	2.0	1.6	0.2	2.8	0.6	0.3	1.9	6.4	5.0	0.6	0.0	0.3	6.0	2.8	0.5	0.3	0.7	0.2	2.1	0.7	0.8	3.7	4.0	0.3	0.1	0.5	1.7	0.3	0.3	0.9	56.6	0.4	1.9	2.5	0.1	0.6	0.8	0.7	0.3	0.5	5.7	2.0	0.6	0.3	0.4	0.5	0.0	0.0	0.3	0.0	0.1	1.1	0.8	0.1	0.3	0.0	0.1	0.0	2.9	0.1	0.1	0.2	0.1	0.5	0.1	0.0	3.3	2.7	0.0	0.2	0.0	0.5	0.0	0.1	3.0	0.1	0.0	2.0	0.0	0.0	0.0	3.4	1.1	0.5	0.2	0.6	0.2	1.7	0.4	0.2	0.1	0.0	0.0	0.3	0.0	3.0	0.7	0.5	0.0	1.5	1.2	0.2	0.6	0.2	5.7	13.8	0.0	3.1	0.2	0.0	1.0	2.5	0.3	0.0	0.7	0.0	0.9	0.6	0.2	1.8	2.9	2.0	0.9	0.8	0.9	0.8	0.4	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.6	0.1	0.9	1.9	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.3	0.0	0.1	1.6	2.8	1.9	6.4	0.7	0.8	0.5	1.7	1.9	0.0	0.0	0.0	0.8	3.2	1.3	1.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.5	0.0	0.0	0.0	0.2	0.5	1.7	0.6	0.0	2.8	0.2	0.0	0.0	2.5	0.0	3.3	1.1	0.5	5.0	0.0	0.0	2.7	0.4	0.0	1.1	4.4	2.4	12.9	4.2	0.2	0.9	1.3	0.3	6.9	0.0	0.4
TIGD4		ENSG00000169989	"Tigger transposable element derived 4"	Q8IY51	4	152769354-152779764	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 14.1;testis: 11.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 76.3;Rod photoreceptor cells: 29.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.6;U-266/70: 6.8;U-266/84: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035649, HPA073768"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA035649: AB_10670956, HPA073768: "	"unprognostic (1.71e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.23e-4)"	"unprognostic (6.19e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.47e-2)"	0.7	1.0	2.2	0.7	8.6	0.2	2.1	3.5	3.6	2.5	0.8	2.1	3.9	1.1	2.0	4.2	0.6	5.5	0.8	1.0	4.8	2.1	2.0	0.6	3.5	0.5	1.6	3.2	1.7	0.9	5.4	14.1	0.5	5.8	1.3	0.9	5.4	2.0	1.1	1.2	1.3	0.8	0.9	2.7	0.8	1.0	11.8	1.3	0.3	2.1	0.6	0.5	1.0	0.8	0.4	0.0	1.6	1.1	2.1	1.3	0.0	0.6	0.5	3.0	1.2	0.2	0.4	0.3	0.1	0.7	0.3	0.6	0.6	1.3	1.0	0.1	0.1	1.4	0.5	1.1	0.5	0.5	1.0	0.2	1.5	0.7	0.3	0.2	0.6	0.3	0.1	0.5	0.5	0.3	0.6	0.1	2.2	0.4	4.6	0.3	0.3	2.9	0.4	1.4	0.4	0.4	0.5	0.6	0.0	2.0	0.1	1.4	1.6	0.2	0.3	2.9	1.4	0.7	0.2	0.0	0.4	0.6	0.5	0.6	6.8	13.2	0.6	1.0	1.6	2.2	0.0	0.3	0.8	0.0	1.1	0.2	0.0	0.3	1.3	0.0	0.4	0.1	0.4	1.6	2.1	0.2	0.0	0.0	0.0	2.2	8.6	3.5	3.6	4.8	2.1	1.6	3.2	5.8	1.3	0.0	1.0	0.0	0.4	0.0	6.7	0.0	0.0	12.0	0.0	1.8	11.8	0.1	0.0	0.5	76.3	0.1	0.0	0.0	1.0	0.1	0.1	0.3	0.0	0.0	0.5	1.6	1.2	0.0	0.0	8.5	0.3	0.0	0.0	0.0	0.1	12.1	0.4	0.0	0.4	1.5	29.0	0.0	0.0	5.1	1.7	0.0	0.2	0.0	0.4	0.3
TRHR		ENSG00000174417	"Thyrotropin releasing hormone receptor"	P34981	8	109086621-109119584	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Congenital hypothyroidism, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 1.0;pituitary gland: 3.3;thyroid gland: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 1.6;SH-SY5Y: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055162	Approved					NA	NA					"HPA055162: AB_2732592"										"unprognostic (1.92e-2)"				"unprognostic (8.58e-2)"		"unprognostic (1.17e-1)"		0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	1.0	0.0	0.2			0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	3.3	0.0		0.0	0.3		0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0			1.6		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.2	0.3	0.6	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSHB		ENSG00000134200	"Thyroid stimulating hormone beta"	P01222	1	115029824-115034309	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	77	"pituitary gland: 192.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"JURKAT: 1.2;SH-SY5Y: 1.0;U-937: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB022202, HPA042681"	Enhanced				"Secreted to blood"	NA	NA					"CAB022202: , HPA042681: AB_2732500"											"unprognostic (2.14e-4)"	"unprognostic (1.37e-1)"		"unprognostic (1.73e-1)"				0.1	0.0	0.1	0.9	0.1	2.4	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	1.4	0.1	1.4	0.0	1.8	0.1	0.1	0.0	0.3	0.1	1.4	0.1	0.1	0.1	0.1	1.6	0.0	192.4	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.1	0.1	0.1	0.4	1.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.1	2.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165593	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 59.4;pituitary gland: 30.4"	"Group enriched"	"Detected in many"	7	"Horizontal cells: 212.9;Intestinal endocrine cells: 123.0"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 36.7;SK-MEL-30: 99.1;U-2 OS: 18.0;WM-115: 29.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1270000	2800000	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavorable (4.25e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	3.8	3.1	10.9	2.3	25.2	1.3	1.1	1.3	59.4	1.1	1.5	1.3	0.0	1.3	2.2	1.1	1.1	1.1	1.2	1.2	12.2	51.0	1.4	1.1	1.1	1.1	3.9	22.8	1.1	6.2	1.1	30.4	1.2	41.2	1.2	1.2	0.5	1.1	1.1	1.1	1.4	1.3	1.5	6.6	1.2	3.6	1.4	0.5	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	2.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	0.0	4.7	0.0	0.4	3.7	0.2	0.4	0.1	0.0	0.0	0.0	0.0	3.0	36.7	0.0	0.1	99.1	0.2	0.1	0.0	0.0	0.0	18.0	0.0	0.4	0.0	0.1	0.9	2.9	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	25.2	1.3	59.4	12.2	51.0	3.9	22.8	41.2	0.5	0.0	0.0	0.0	1.0	1.3	8.5	2.4	0.0	0.0	0.0	0.0	0.0	1.3	24.9	0.3	0.0	0.3	1.3	0.0	0.0	6.3	0.2	2.8	0.0	0.0	0.5	212.9	123.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	1.4	9.5	2.9	0.0	1.0	4.5	0.0	0.2	0.2	4.2	1.9	1.1	0.0	0.9	0.5
WDR19	"DYF-2, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp"	ENSG00000157796	"WD repeat domain 19"	Q8NEZ3	4	39182404-39285810	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 41.1"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 41.5;Spermatocytes: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;ASC TERT1: 28.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039616, HPA058847"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039616: AB_10796331, HPA058847: AB_2683834"	"unprognostic (1.80e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.40e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"prognostic favorable (2.70e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-2)"	8.5	7.6	8.1	4.8	12.9	3.4	9.2	21.0	14.5	13.2	7.8	5.7	7.8	1.9	15.5	11.2	5.4	20.9	8.6	5.1	11.7	4.1	8.6	7.0	8.6	4.4	6.0	11.0	19.0	6.6	10.1	41.1	6.3	14.6	8.1	4.3	6.9	7.6	8.2	3.1	6.0	5.7	9.5	9.7	4.3	8.0	12.7	7.3	6.8	17.1	3.8	5.0	9.9	8.9	3.9	1.1	1.5	2.0	2.3	2.4	0.8	3.2	2.3	5.5	6.6	25.4	28.5	2.5	4.3	9.7	4.5	6.0	1.4	3.7	5.3	2.1	4.1	9.7	1.9	5.4	2.8	5.0	0.3	3.9	1.0	4.4	2.7	7.9	5.2	1.4	17.3	6.1	6.0	3.8	12.5	5.4	5.4	4.7	5.3	5.4	1.1	3.5	3.6	1.8	1.9	2.6	4.3	5.6	2.4	3.7	1.3	6.1	5.6	4.2	1.4	2.8	6.9	2.8	1.9	3.9	4.4	3.0	9.7	4.2	3.9	3.6	3.7	6.6	1.5	2.0	0.7	1.2	0.9	1.7	2.0	1.3	3.4	2.1	2.4	1.1	3.9	2.1	2.1	1.5	2.3	1.7	0.7	1.4	0.8	8.1	12.9	21.0	14.5	11.7	4.1	6.0	11.0	14.6	7.3	11.9	5.7	3.2	4.9	4.2	7.6	3.8	2.5	41.5	12.5	17.4	9.8	1.0	0.0	4.5	3.0	4.5	0.0	0.0	3.1	2.0	5.6	3.1	2.3	10.6	2.7	23.8	2.4	4.3	1.9	2.6	15.3	2.9	1.7	1.0	2.2	7.3	2.9	0.0	17.7	3.4	22.5	0.0	3.8	30.3	10.2	4.1	1.1	1.0	1.0	1.8
ZBTB8B	"DKFZp547H154, RP1-27O5.1, ZNF916B"	ENSG00000273274	"Zinc finger and BTB domain containing 8B"	Q8NAP8	1	32465069-32496686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 10.8"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 5.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RT4: 3.6;SCLC-21H: 3.6"									HPA055553	Enhanced					NA	NA					"HPA055553: AB_2682848"	"unprognostic (8.32e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.83e-5)"	"unprognostic (1.86e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.67e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.88e-3)"	0.4	1.3	5.1	0.6	2.8	2.5	0.6	2.2	5.0	0.4	0.3	1.3	0.7	0.5	1.2	1.3	0.7	0.7	0.6	0.4	3.3	4.7	0.6	0.6	0.5	0.9	2.6	2.7	1.0	0.8	1.0	10.8	0.7	4.1	0.8	0.4	0.2	1.7	0.5	3.4	1.7	0.5	0.5	1.6	0.8	0.5	3.1	1.6	0.0	0.8	0.0	0.6	1.0	0.4	1.4	1.2	3.2	0.8	1.3	0.7	0.2	0.2	0.1	2.0	1.5	0.2	0.5	0.6	0.2	0.1	0.7	0.6	0.2	0.5	0.4	0.7	0.1	1.1	0.7	2.3	0.2	0.5	0.7	2.4	0.3	0.7	0.4	0.0	0.3	0.4	0.2	0.2	0.5	0.0	0.4	0.2	0.2	0.2	0.9	0.1	0.3	0.3	0.6	2.1	0.1	0.9	0.3	0.2	0.3	0.4	3.6	3.6	2.1	1.3	0.5	0.2	2.9	0.4	0.3	0.9	0.5	0.4	0.6	0.3	0.7	0.7	0.4	0.5	0.4	0.4	3.2	0.8	1.0	0.6	0.5	0.6	0.8	0.6	0.5	0.3	1.4	0.7	0.7	2.9	1.3	0.7	1.2	0.5	0.2	5.1	2.8	2.2	5.0	3.3	4.7	2.6	2.7	4.1	1.6	0.0	2.6	0.0	0.8	1.4	2.9	0.6	0.0	2.7	1.2	0.0	5.9	1.5	0.0	0.0	1.5	0.7	0.0	0.0	0.0	1.0	0.8	0.7	3.5	0.2	0.3	3.2	0.0	1.3	0.3	1.0	0.6	1.5	1.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.3	1.9	1.2	0.5	0.2	1.0	0.0	0.7